Amyloid beta and tau proteins compete for the same binding sites on microtubules in neurons, suggesting that displacement of tau by amyloid beta, rather than aggregation of either protein, may be the ...

A study published Wednesday in Nature Neuroscience sheds light into how amyloid-beta and tau proteins impact brain activity and contribute to cognitive decline. Amyloid-beta and tau proteins have been ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the two key pathological hallmarks of Alzheimer's-tau protein and beta-amyloid ...

A new experimental Alzheimer’s compound called FLAV-27 improved memory and reduced disease-like damage in worms and mice.

New research reveals how the combined impact of amyloid-β and tau deposits alters brain activity patterns in older adults, providing key insights into early Alzheimer’s disease progression. Study: ...

Drugs best known for helping people lose weight may also chip away at the proteins that define Alzheimer’s disease. A ...

Using a new animal model of Alzheimer’s disease, the study suggests a potential breakthrough in treatment strategies. Current therapies mainly focus on blocking just one of the toxic proteins ...

Turning its focus to neurology and following a successful acquisition of Life Molecular Imaging, Lantheus is on the path to revolutionize Alzheimer’s disease diagnosis by advancing its two late-stage ...

Biogen advances Alzheimer's drug diranersen to late-stage trials after a phase II study misses its main goal but shows ...

Alzheimer's pathology was common in other dementias. An Alzheimer's biomarker profile was seen in unspecified dementia, Parkinson's dementia, and frontotemporal dementia. Biomarkers indicating ...